[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:cirrhosis":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":312,"states":313},"Cirrhosis",79,64,[8,16,23,30,36,42,48,54,60,66,73,80,86,91,97,103,109,115,122,128,134,140,146,152,158,164,170,176,182,188,194,200,206,212,218,224,230,235,241,247,253,259,265,271,277,283,289,295,301,306],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05201404","Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis",[12],"Phase 3","RECRUITING","2026-08-26T02:17:04.346841Z","2026-05-05T02:43:29.480229Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05548452","Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease",[20],"Phase 1\u002FPhase 2","2026-08-03T03:34:46.909700Z","2026-05-05T02:43:29.479039Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT05867602","High Dose Albumin in Refractory Ascites",[27],"Phase 2","2026-08-26T02:16:28.221034Z","2026-05-05T02:43:29.386051Z",{"nct_id":31,"title":32,"phases":33,"status":13,"updated_at":34,"content_modified":35},"NCT07325526","A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)",[27],"2026-08-26T02:18:52.966503Z","2026-05-05T02:43:29.326337Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT07046429","Affect of Melatonin on Sleep and Cognition in Cirrhosis",[],"2026-08-26T02:17:54.420226Z","2026-05-05T02:43:29.320515Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT07471542","Copper Supplementation in Cirrhosis",[],"2026-08-26T02:17:59.904383Z","2026-05-05T02:43:29.187694Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT06920043","A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH",[27],"2026-08-26T02:18:30.351130Z","2026-05-05T02:43:28.874655Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT04873102","Danazol for Treatment of Cytopenias in Patients With Cirrhosis",[27],"2026-08-26T02:19:31.671303Z","2026-05-05T02:43:28.646278Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT06425380","Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy",[],"2026-08-26T02:18:47.742071Z","2026-05-05T02:43:28.129051Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":71,"content_modified":72},"NCT06007846","A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer",[70],"Phase 2\u002FPhase 3","2026-08-26T02:17:18.747857Z","2026-05-05T02:43:27.996906Z",{"nct_id":74,"title":75,"phases":76,"status":13,"updated_at":78,"content_modified":79},"NCT05045482","Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease",[77],"Phase 1","2026-08-26T02:17:57.117858Z","2026-05-05T02:43:27.975021Z",{"nct_id":81,"title":82,"phases":83,"status":13,"updated_at":84,"content_modified":85},"NCT05484206","Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434",[77],"2026-08-26T02:15:43.339060Z","2026-05-05T02:43:27.914197Z",{"nct_id":87,"title":88,"phases":89,"status":13,"updated_at":28,"content_modified":90},"NCT05832229","Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States",[27],"2026-05-05T02:43:27.134034Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":95,"content_modified":96},"NCT05490888","Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics",[77],"2026-08-26T02:18:22.309547Z","2026-05-05T02:43:27.074409Z",{"nct_id":98,"title":99,"phases":100,"status":13,"updated_at":101,"content_modified":102},"NCT06526104","Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis",[27],"2026-08-26T02:16:45.157238Z","2026-05-05T02:43:26.665362Z",{"nct_id":104,"title":105,"phases":106,"status":13,"updated_at":107,"content_modified":108},"NCT06941415","Bumetanide vs. Furosemide in Cirrhosis",[12],"2026-08-26T02:15:14.574786Z","2026-05-05T02:35:31.863075Z",{"nct_id":110,"title":111,"phases":112,"status":13,"updated_at":113,"content_modified":114},"NCT07335601","Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH",[27],"2026-08-26T02:18:58.958025Z","2026-07-05T05:32:16.677970Z",{"nct_id":116,"title":117,"phases":118,"status":13,"updated_at":120,"content_modified":121},"NCT07058155","Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease",[119],"Phase 4","2026-08-26T02:19:05.360997Z","2026-05-05T02:43:29.218624Z",{"nct_id":123,"title":124,"phases":125,"status":13,"updated_at":126,"content_modified":127},"NCT06525623","Initial Resuscitation for Acute Kidney Injury in Cirrhosis",[],"2026-08-26T02:16:44.178623Z","2026-05-05T02:43:28.843858Z",{"nct_id":129,"title":130,"phases":131,"status":13,"updated_at":132,"content_modified":133},"NCT06871111","The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial",[77],"2026-08-26T02:17:58.890423Z","2026-05-05T02:43:28.508280Z",{"nct_id":135,"title":136,"phases":137,"status":13,"updated_at":138,"content_modified":139},"NCT06932783","Remote Electrical Stimulation for Pain and Depression Treatment in Cirrhosis",[],"2026-08-26T02:17:13.277148Z","2026-05-05T02:43:27.518732Z",{"nct_id":141,"title":142,"phases":143,"status":13,"updated_at":144,"content_modified":145},"NCT07358546","A Study of Efimosfermin Alfa in Adults With Hepatic Impairment",[77],"2026-08-26T02:16:54.876240Z","2026-07-05T05:32:16.678763Z",{"nct_id":147,"title":148,"phases":149,"status":13,"updated_at":150,"content_modified":151},"NCT03208868","Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis",[],"2026-08-26T02:18:37.277498Z","2026-05-05T02:43:29.371687Z",{"nct_id":153,"title":154,"phases":155,"status":13,"updated_at":156,"content_modified":157},"NCT05486572","Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI",[],"2026-08-26T02:15:37.042762Z","2026-05-05T02:43:29.351159Z",{"nct_id":159,"title":160,"phases":161,"status":13,"updated_at":162,"content_modified":163},"NCT04096014","Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy",[],"2026-08-26T02:18:31.944757Z","2026-05-05T02:43:29.138184Z",{"nct_id":165,"title":166,"phases":167,"status":13,"updated_at":168,"content_modified":169},"NCT06015022","EGCG for Hepatocellular Carcinoma Chemoprevention",[27],"2026-08-26T02:17:43.321968Z","2026-05-05T02:43:28.807892Z",{"nct_id":171,"title":172,"phases":173,"status":13,"updated_at":174,"content_modified":175},"NCT05028829","Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk",[27],"2026-08-26T02:15:26.669629Z","2026-05-05T02:43:28.282869Z",{"nct_id":177,"title":178,"phases":179,"status":13,"updated_at":180,"content_modified":181},"NCT04588077","Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis",[119],"2026-08-26T02:17:11.311767Z","2026-05-05T02:43:27.918762Z",{"nct_id":183,"title":184,"phases":185,"status":13,"updated_at":186,"content_modified":187},"NCT06052176","Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement",[27],"2026-08-03T02:40:44.217164Z","2026-05-05T02:43:27.635930Z",{"nct_id":189,"title":190,"phases":191,"status":13,"updated_at":192,"content_modified":193},"NCT06184152","CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules",[],"2026-08-26T02:18:56.409949Z","2026-05-05T02:43:27.760541Z",{"nct_id":195,"title":196,"phases":197,"status":13,"updated_at":198,"content_modified":199},"NCT03694691","Developing Viability Index for Machine Perfused Livers",[],"2026-08-26T02:15:02.712396Z","2026-05-05T02:43:26.719409Z",{"nct_id":201,"title":202,"phases":203,"status":13,"updated_at":204,"content_modified":205},"NCT05304234","Liver Cancer Disparities in American Indian and Alaska Native Persons",[27],"2026-08-26T02:17:28.381459Z","2026-04-29T02:57:57.073818Z",{"nct_id":207,"title":208,"phases":209,"status":13,"updated_at":210,"content_modified":211},"NCT05477277","Adverse Outcomes and Mortality in Liver Transplant",[],"2026-08-26T02:19:23.493898Z","2026-05-05T02:43:29.068900Z",{"nct_id":213,"title":214,"phases":215,"status":13,"updated_at":216,"content_modified":217},"NCT06084234","National Liver Cancer Screening Trial",[119],"2026-08-26T02:16:09.452956Z","2026-05-05T02:43:28.172694Z",{"nct_id":219,"title":220,"phases":221,"status":13,"updated_at":222,"content_modified":223},"NCT07658222","Prospective Investigation of Cirrhotic Cardiomyopathy in Humans",[],"2026-08-26T02:15:28.524219Z","2026-06-18T12:24:03.102955Z",{"nct_id":225,"title":226,"phases":227,"status":13,"updated_at":228,"content_modified":229},"NCT07191886","Measuring Patient Reported Needs in Outpatient Liver Disease Management",[],"2026-08-26T02:19:19.975067Z","2026-05-13T02:55:06.669962Z",{"nct_id":231,"title":232,"phases":233,"status":13,"updated_at":222,"content_modified":234},"NCT06950788","Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant",[],"2026-05-13T02:55:06.593930Z",{"nct_id":236,"title":237,"phases":238,"status":13,"updated_at":239,"content_modified":240},"NCT05199259","Multi-analyte Blood Test Clinical Trial",[],"2026-08-26T02:19:03.581490Z","2026-05-13T02:55:06.295420Z",{"nct_id":242,"title":243,"phases":244,"status":13,"updated_at":245,"content_modified":246},"NCT04662918","Validation of CAGIB Score for In-hospital Mortality of Cirrhotic Patients With Acute Gastrointestinal Bleeding",[],"2026-08-26T02:16:07.529922Z","2026-05-13T02:55:06.257687Z",{"nct_id":248,"title":249,"phases":250,"status":13,"updated_at":251,"content_modified":252},"NCT04613921","Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs",[],"2026-08-26T02:16:50.548894Z","2026-05-13T02:55:06.256154Z",{"nct_id":254,"title":255,"phases":256,"status":13,"updated_at":257,"content_modified":258},"NCT03225677","Novel Tracer Methods to Evaluate Muscle Protein Metabolism in Cirrhosis",[],"2026-08-26T02:15:53.461103Z","2026-05-13T02:55:06.119636Z",{"nct_id":260,"title":261,"phases":262,"status":13,"updated_at":263,"content_modified":264},"NCT03228290","Functional Assessment in Liver Transplantation",[],"2026-08-26T02:17:00.709807Z","2026-05-13T02:55:06.109887Z",{"nct_id":266,"title":267,"phases":268,"status":13,"updated_at":269,"content_modified":270},"NCT03121404","Mechanisms of Malnutrition in Cirrhosis With Portosystemic Shunting",[],"2026-08-26T02:15:47.754948Z","2026-05-13T02:55:06.108494Z",{"nct_id":272,"title":273,"phases":274,"status":13,"updated_at":275,"content_modified":276},"NCT07122700","Evaluation of Non-Invasive Tests for Metabolic Liver Disease",[],"2026-08-26T02:15:09.079045Z","2026-05-13T02:55:06.656773Z",{"nct_id":278,"title":279,"phases":280,"status":13,"updated_at":281,"content_modified":282},"NCT07010315","Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention",[],"2026-08-26T02:19:27.519777Z","2026-05-13T02:55:06.605734Z",{"nct_id":284,"title":285,"phases":286,"status":13,"updated_at":287,"content_modified":288},"NCT06306963","Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias",[],"2026-08-26T02:18:55.570428Z","2026-05-13T02:55:06.434542Z",{"nct_id":290,"title":291,"phases":292,"status":13,"updated_at":293,"content_modified":294},"NCT06265272","Value of [68Ga]Ga-PSMA-11 PET\u002FMRI in the Assessment of Liver Cirrhosis",[],"2026-08-26T02:19:11.399072Z","2026-05-13T02:55:06.429899Z",{"nct_id":296,"title":297,"phases":298,"status":13,"updated_at":299,"content_modified":300},"NCT05181826","Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer",[],"2026-08-26T02:16:24.970704Z","2026-07-19T19:36:05.131295Z",{"nct_id":302,"title":303,"phases":304,"status":13,"updated_at":78,"content_modified":305},"NCT05463796","InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer",[],"2026-05-13T02:55:06.364704Z",{"nct_id":307,"title":308,"phases":309,"status":13,"updated_at":310,"content_modified":311},"NCT03025074","Blood Collection Biorepository for Liver Disease Research",[],"2026-08-26T02:16:46.951087Z","2026-05-13T02:55:06.105869Z",[],[314,318,322,326,329,333,337,341,344,348,352,356,359,363,366,370,373,377,380,383,386,389],{"state":315,"count":316,"slug":317},"Texas",25,"texas",{"state":319,"count":320,"slug":321},"California",20,"california",{"state":323,"count":324,"slug":325},"New York",13,"new-york",{"state":327,"count":324,"slug":328},"Ohio","ohio",{"state":330,"count":331,"slug":332},"Pennsylvania",12,"pennsylvania",{"state":334,"count":335,"slug":336},"Massachusetts",11,"massachusetts",{"state":338,"count":339,"slug":340},"Florida",10,"florida",{"state":342,"count":339,"slug":343},"Illinois","illinois",{"state":345,"count":346,"slug":347},"Virginia",9,"virginia",{"state":349,"count":350,"slug":351},"Minnesota",8,"minnesota",{"state":353,"count":354,"slug":355},"Michigan",7,"michigan",{"state":357,"count":354,"slug":358},"North Carolina","north-carolina",{"state":360,"count":361,"slug":362},"Maryland",6,"maryland",{"state":364,"count":361,"slug":365},"Tennessee","tennessee",{"state":367,"count":368,"slug":369},"Arizona",5,"arizona",{"state":371,"count":368,"slug":372},"Indiana","indiana",{"state":374,"count":375,"slug":376},"Colorado",4,"colorado",{"state":378,"count":375,"slug":379},"Connecticut","connecticut",{"state":381,"count":375,"slug":382},"Georgia","georgia",{"state":384,"count":375,"slug":385},"Utah","utah",{"state":387,"count":375,"slug":388},"Washington","washington",{"state":390,"count":391,"slug":392},"District of Columbia",3,"district-of-columbia"]